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Immunoprecipitation and western analysis were conducted in order to detect
the formation of each growth factor-integrin complex. Confocal microscopy was
used in order to perform immunofluorescence, detecting the above mentioned
complex formations.
Results: The application of both agents either alone or in combination showed
significant reduction in proliferation and chemotactism in both cell lines. There
was also an induction of apoptosis in both cell lines. MMP levels were down
regulated in M059K cells while there was no change of MMP levels in U87 cells.
Lapatinib intercepted the formation of EGFR-integrinb1 complex, in both cell
lines while sunitinib intercepted VEGFR-integrinb3 complex formation in U87
cells. Immunofluorescence revealed colocalisation of molecules in the above
mentioned complexes and their disengagement after application of agents in
a time course manner.
Conclusions: Lapatinib and Sunitinib have a strong inhibitory effect.
Combinational dosing of these agents has a better and stronger effect in the
above mentioned parameters than each one of them on its own. The current
data showed an implication of the tested agents in the integrin – growth faxtor’s
pathway.
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Background: Caveolin-1 (cav1) plays a crucial role in cancer development
and progression. Although caveolin-1 expression is increased in glioma, cav1
negative (cav1low) and positive (cav1high) cells coexist in glioblastoma (GBM).
We reported that cav1low GBM cells exerted a more aggressive phenotype
than cav1high GBM cells, suggesting that cav1 is a tumour suppressor in
brain tumours. Transcriptomic analysis showed that cav1 represses integrins
especially a5b1 integrin so that cav1 and a5b1 integrin expressions were
inversely correlated. We identified a5b1 integrin as the mediator of cav1’s effect
in GBM. This study focused on the mechanisms by which cav1 regulate a5b1
integrin expression.
Material and Methods: 6 different GBM cell lines were used. Some were
silenced (using si/shRNAcav1) or forced to express (pEGFPcav1) cav1. TGFb
was quantified using a commercially available kit. Protein expression and
activity was determined by western blot. Drugs used were SB431542,
LY294002 and U0126 (inhibiting the TGFb receptor, Pi3K and MEK1
respectively), K34c (a a5b1 integrin antagonist), TGFb and activin. Surviving
fraction after drug treatment was determined by clonogenic assays. Gene
expression was studied by qPCR.
Results: Cav1 affects the TGFb/Smad2 pathway, previously identified as a
regulator of integrin expression. Silencing cav1 increased the secretion of
TGFb, the expression of TGFb receptor and the activity of its downstream
effector Smad2. Conversely, forced expression of cav1 repressed the
TGFb/Smad2 pathway so that cav1 expression and TGFb/Smad2 activity
are inversely correlated. Using selective inhibitors, we showed that the
TGFb/Smad2 pathway was involved in the regulation of a5b1 integrin
expression by cav1. Two Smad2-dependent signaling pathways were involved;
one independent on the TGFbRI (cav1 → ERK → Smad2 → a5b1 integrin)
and one dependent on the TGFbRI (cav1 → TGFbRI → Pi3K/Akt →
Smad2 → a5b1 integrin). Therefore, cav1low cells exert high level of
TGFbRI/Smad and a5b1 integrin and vice and versa. The reverse correlation
between cav1 and a5b1/TGFb/Smad2 was confirmed in different GBM cell
lines. Finally, we showed that cav1low/a5b1/TGFb/Smadhigh cells (identified as
being the most aggressive) are highly sensitive to SB431542 and K34c.
Conclusions: Cav1 controls a5b1 integrin expression through the TGFb/
Smad2 pathway. The status of cav1/a5b1/TGFb/Smad2 might be a useful
marker of the tumour behavior and a predictor of anti-TGFb or anti-a5b1 integrin
therapies.
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Background: It was demonstrated that mixed steroidal tetraoxanes inhibit
cancer cell proliferation at micromolar level through an apoptotic mechanism.
It will be interesting to see if these compounds may possibly induce oxidative
stress, which could lead to induction of apoptosis in tumour cells. As tumour
cells contain more iron than other normal tissues it is reasonable to suggest
that tetraoxanes could react with iron, generating alkoxy radicals or even highly
reactive hydroxyl radicals in a Fenton-like reaction. To gain further insight
into the mechanism of cell death induced by tetraoxane endoperoxides, we
tested production of reactive oxygen species (ROS) and level of activation of
caspase 3 in tumour cells treated with several newly synthesized tetraoxanes.
Material and Methods: Stock solutions of investigated tetraoxanes, were
prepared in DMSO at concentrations of 10mM and afterwards they were
diluted with complete nutrient medium to various final concentrations. Target
cells used were malignant cervix carcinoma HeLa cells.
Production of intracellular ROS was measured using the fluorescent dye
2′,7′-dichlorofluorescein diacetate, a nonpolar compound that readily diffuses
into cells, where it is hydrolyzed to 2′,7′-dichlorofluorescein (H2DCFDA), a
nonfluorescent polar compound. In the presence of an oxidizing compound,
H2DCFDA is converted into highly fluorescent 2
′,7′-dichlorofluorescein.
Level of active caspase 3 is measured using the caspase 3 fluorimetric
assay kit (Sigma Chemicals), based on the hydrolysis of the peptide
substrate by caspase 3, resulting in the release of the fluorescent 7-amino-4-
methylcoumarin moiety.
Results: After treatment with investigated tetraoxanes ROS level in HeLa cells
significantly increased indicating possible oxidative stress, maybe as a result
of the production of reactive alkoxy or hydroxyl radicals. Significant increase
in activity of caspase 3 was observeded after incubation of HeLa cells with all
investigated tetraoxanes.
Conclusion: Taken together, these results demonstrate that tetraoxanes
potently generates ROS, and strongly inhibits the growth of HeLa cells
throughout apoptosis. Although the mechanisms by which mixed tetraoxanes
activates caspase 3 in HeLa cells remains unclear, those results provide
correlation between ROS production, caspase 3 activity and tetraoxanes-
induced apoptosis.
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Background: Epidemiological studies indicate that breast is one of the
most susceptible organs to radiation-induced carcinogenesis. Most studies,
however, have failed in identifying clear genetic alterations in radiation-induced
breast/mammary cancers. The Copenhagen (COP) rats are completely
resistant, whereas Sprague-Dawley (SD) rats are highly susceptible, to
chemically-induced mammary carcinogenesis, and this resistance of the COP
background is regarded as a dominant trait.
Material and Methods: Mammary cancer-prone SD, -resistant COP, and their
hybrid (SD×COP) F1 rats were irradiated with gamma-rays at 4 Gy and
underwent autopsy at the time of spontaneous death or at 1.5 years post-
irradiation. Genomic DNA was extracted from mammary cancers and ear skins
of corresponding individuals. Genome-wide DNA copy number was analyzed
by array comparative genomic hybridization (aCGH).
Results: COP rats were resistant to radiation-induced mammary carcinogen-
esis. Interestingly, F1 rats showed a relatively susceptible trait, suggesting
recessive inheritance of the resistance to radiation-induced mammary
carcinogenesis. The preliminary results of aCGH analysis indicated that partial
deletions of the proximal region of chromosome 2, where Mcs-1 (mammary
cancer susceptibility gene-1 for chemical carcinogenesis) is mapped, were
occasionally observed, suggesting a tumour suppressive role of Mcs-1 in
radiation carcinogenesis. Other aberrations including small deletions and
aneuploidy were also frequent but scattered throughout the genome.
Conclusions: These findings implicate that radiation-induced rat mammary
cancers are rather heterogeneous with regard to copy number changes. The
frequent deletion of COP alleles suggests that these tumour suppressive
alleles may be readily targeted by radiation but not carcinogenic chemicals.
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Background: Cadherins are cell-cell adhesion molecules. During tumour
progression, their expression and/or function are frequently altered. E-cadherin
down-regulation is often associated with tumour initiation and progression in
breast cancer, whereas P-cadherin overexpression is associated with a worse
patient survival, as well as with invasive breast cancer cells. In this study,
we aimed to understand if P-cadherin overexpression could interfere with
E-cadherin invasion suppressor role in breast cancer.
Materials and Methods: E- and P-cadherin expression was evaluated in
a series of invasive breast carcinomas. The results were correlated with
prognosis and clinico-pathological parameters. To study the functional value
of E- and P-cadherin co-expression, we silenced the transcription of both
cadherins in BT-20 breast cancer cells, and investigated the in vitro effects
